SUMMARY -Heart rate variability (HRV) gives information on the sympathetic-parasympathetic autonomic balance. Th e aim of the study was to analyze sympathovagal balance after acute spinal cord injury (SCI), demonstrated by linear measures in time and frequency domain of HRV and to analyze the eff ect of corticosteroids on HRV parameters in SCI. Th e study included 40 tetraplegic patients with acute SCI and 40 healthy subjects as control group. In the SCI group, 29 patients received and 11 patients did not receive corticosteroid therapy. All patients underwent 24-hour Holter monitoring for evaluation of HRV. Cardiac autonomic balance was evaluated by analysis of HRV in time and frequency domain. Sympathovagal balance (LF/HF) was signifi cantly reduced in the groups of acute SCI patients, both with and without corticosteroid therapy, as compared with controls. However, there was no statistically signifi cant diff erence between the two SCI groups (1.74 (0524) with and 1.75 (0534) without corticosteroid therapy). Th is study showed the sympathovagal balance to be altered in the acute phase of cervical spinal cord trauma. Finally, there was no eff ect of corticosteroid therapy on HRV parameters in SCI patients.
Introduction
Spinal cord injury (SCI) is an insult to the spinal cord resulting in a change, either temporary or permanent, in the cord normal motor, sensory, or autonomic function 1 . One of the most debilitating secondary consequences of SCI is alteration in autonomic cardiovascular control that, combined with paralysis, predisposes individuals with SCI to a higher incidence of cardiovascular disease. Th ey frequently exhibit arrhythmias, refl ex bradycardia and cardiac arrest 2 .
Patients having sustained complete injury, with no motor function or sensation below the level of the spinal cord lesion according to the American Spinal Injury Association (ASIA) standards 3 have a much higher incidence of autonomic dysrefl exia (91% with complete injury vs. 27% with incomplete injury). Autonomic dysrefl exia (AD) can lead to sequels of cardiovascular eff ects, such as myocardial infarction, intracranial hemorrhage, and even death 4 . Autonomic eff erent pathways of cardiovascular regulation are severely impaired in patients with tetraplegia. SCI with resultant quadriplegia is associated with signifi cant dysfunction of the sympathetic nervous system. Sympathetic preganglionic neurons in the thoracic and upper lumbar segment of the spinal cord lose supraspinal control due to cervical SCI. Parasympathetic preganglionic fi bers passing through va-gal nerves, which originate from the brainstem, remain intact 5 . Th e current ASIA standards for SCI assessment do not evaluate the severity of injury to autonomic pathways. Th e diagnosis of autonomic neuropathy depends on the results of tests that elicit refl ex changes in heart rate 6 . One of the best noninvasive markers of autonomic nervous system function is analysis of the heart rate variability (HRV) 7 . Analysis of HRV has been used to assess autonomic function. It is altered in many diseases [8] [9] [10] [11] . Th e parameters of HRV have been studied in patients with SCI and calculated from 24-hour Holter electrocardiogram (ECG) 12, 13 . Th e aim of this study was to analyze sympathovagal balance after acute SCI as demonstrated by linear measures in time and frequency domain and to compare sympathovagal balance between tetraplegic patients administered and those not administered corticosteroid therapy. Th e aim was also to observe the effects of corticosteroids on HRV parameters.
Patients and Methods
Th e study included 40 patients (30 male and 10 female) with acute cervical SCI and 40 (31 male and 9 female) healthy subjects matched for age and sex. In the SCI group, 29 patients received and 11 patients did not receive corticosteroid therapy. Inclusion criteria were, as we previously reported 14 , age under 70, cervical SCI with clinically complete motor and sensory loss under the level of injury, and sinus rhythm on ECG. Exclusion criteria were atrial fi brillation, AV block, diabetes mellitus, heart failure, and beta adrenergic blockers or antiarrhythmic drugs in therapy. None of the subjects had cardiopulmonary disease or used drugs that may infl uence HRV parameters.
Th e diagnosis of tetraplegia was made by neurological examination by a specialist according to the 1996 ASIA standards 3 . It is based on neurological responses, touch and pinprick sensations tested in each dermatome, and strength of the muscles that control key motions on both sides of the body, including, shoulder shrug (C4), elbow fl exion (C5), wrist extension (C6), elbow extension (C7), fi nger fl exion (C8) and small fi nger abductors (Th 1), hip fl exion (L2), thigh adduction, extension of leg at the knee (L2, L3, L4), thigh abduction, dorsifl exion of foot, extension of toes (L4, L5, S1), extension of leg at the hip, plantar fl exion of foot and fl exion of toes (L5, S1, S2). Total paralysis of motor strength was considered as complete lesion. Anesthesia and analgesia were considered as complete lesion. Traumatic SCI is classifi ed into fi ve categories on the ASIA Impairment Scale. Th e current standards for assessment of SCI (ASIA) examination do not evaluate the severity of injury to autonomic pathways 3 . Upon physical and radiographic examination to determine the degree and level of injury, some patients were administered anti-edematous therapy, as follows: methylprednisolone in high doses and 30 mg/kg bolus, followed by 5.4 mg/kg every hour. It is necessary to initiate treatment within 8 hours of injury and continue it for 23 hours 15 . Each subject provided a detailed medical history and all patients and controls were evaluated by physical examination and 24-hour Holter monitoring.
Analysis of HRV is a noninvasive and simple test to evaluate the autonomic nervous system function in patients with tetraplegia after SCI 16 . Linear analysis of 24-hour ECG recording was performed on the fi rst day of hospital admission after acute SCI. Th e subjects were monitored with a 24-hour high resolution ECG recorder. Holter ECGs were carefully analyzed by cardiologists. HRV analysis was assessed over 24 hours in time domain and with power spectral analyses. Most of the variables proposed by the Task Force on the Heart Rate Variability were analyzed 17 . Th e following time-domain and power spectral parameters were calculated: time domain analysis included RR I -mean of R-R intervals; SDNN ms -standard deviation of all RR intervals; SDANN ms -standard deviation of the means of RR intervals in all 5-minute segments of the entire recording; RMSSD ms -square root of the mean of the sum of the squares of diff erences between adjacent RR intervals; SDNN index ms -mean of the standard deviations of all RR intervals for all 5-minute segments of the entire recording; SDSD ms -standard deviation of diff erences between adjacent RR intervals; NN50 count -number of pairs of adjacent RR intervals diff ering by more than 50 ms in the entire recording; and pNN50 -% NN50 count divided by the total number of all NN intervals.
Frequency domain analysis covered TP -total power; P -power; VLF -very low frequency (0.003-0.04 Hz); LF -low frequency (0.04-015 Hz); HFhigh frequency (0.15-0.4 Hz); and LH/HF -low to high frequency ratio named sympathovagal balance. LF and HF variables are expressed in mse2. All variables were measured over 23.1-hour period. ECG recordings were made by the CardioMem CM 3000 (Getemed, G.E., Teltow, Germany) 6-channel Holter recorders. HRV was computer analyzed using the CardioDay software.
R-R intervals that included ectopic beats were excluded and extrapolated by linear interpolation. Spectral analysis was computed using fast Fourier transformation 18 . Statistical analysis was performed using SPSS 17.5 (SPSS Inc., New York, USA) in MS Windows 7.
Means ± standard deviation (SD) were calculated. Th e groups were compared by use of Mann-Whitney U test. Between group diff erences in time domain variables were assessed by Student's t-test. Data were tested for normality using Kolmogorov-Smirnov distribution and Shapiro-Wilk test. Th e level of significance was set at p<0.05.
Results
Heart rate variability data derived from 24-hour ECG recordings are shown in Tables 1 and 2 . Table 1 illustrates HRV data in frequency and time domain in SCI patients with and without corticosteroid therapy. ECG = electrocardiography; HRV = heart rate variability; SCI = spinal cord injury; p = test of statistical signifi cance; values are expressed as mean ± standard deviation (SD); TP = total power; P = power; VLF = very low frequency; LF = low frequency; HF = high frequency; LF/HF = low to high frequency ratio; RR I = average value of R-R intervals; SDNN ms = standard deviation of all RR intervals; SDANN ms = standard deviation of the averages of RR intervals in all 5-minute segments of the entire recording; RMSSD ms = square root of the mean of the sum of the squares of diff erences between adjacent RR intervals; SDNN index ms = mean of the standard deviations of all RR intervals for all 5-minute segments of the entire recording; SDSD ms = standard deviation of diff erences between adjacent RR intervals; NN50 count = number of pairs of adjacent RR intervals diff ering by more than 50 ms in the entire recording; pNN50 = % NN50 count divided by the total number of all NN intervals. Table 2 illustrates HRV data in frequency domain in SCI patients and control group.
In a previously published paper, we reported on the predominance of n. parasympathetic in SCI 14 . Time and frequency domain HRV indices were signifi cantly reduced in the SCI groups with and without corticosteroid therapy, as compared with controls. In the present study, however, there was no statistically signifi cant diff erence between the two SCI groups.
Low frequency (LF) in the SCI group with corticosteroid therapy was lower (1.17 (0249)) than in the SCI patients without corticosteroid therapy (1.21 (0145); p=0.060) but the diff erence did not reach statistical signifi cance. High frequency (HF) in the SCI group with corticosteroid therapy was higher (3.38 (1578)) than in the group without corticosteroid therapy (2.94 (1135); p=0.550) but not signifi cantly either. Th e sympathovagal balance, i.e. the low to high frequency ratio (LF/HF) was not statistically signifi cantly diff erent (p=0.858) between the two groups with cervical spine injuries.
All parameters monitored in time domain were not signifi cantly diff erent between the two groups with SCI. Analysis of the HRV parameters in time domain showed the standard deviation of average RR interval of fi ve-minute recording (SDANN) and standard deviation of all RR intervals (SDNN) as a measure of total HRV to be lower, but not signifi cantly, in the SCI group of patients having received corticosteroid therapy. Th e square root of the mean of the sum of the squares of diff erences between adjacent RR intervals (RMSSD) was also lower in the group having received corticosteroid therapy, while the number of adjacent RR intervals that diff ered by more than 50 ms (NN50) and the percentage of adjacent RR intervals that differed by more than 50 ms (pNN50) as measures of parasympathetic activity were higher in the SCI group having received corticosteroid therapy, but not significantly either. Th ese results are contradictory, so further research is needed. However, there was no statistically signifi cant diff erence between the two SCI groups.
Discussion
Autonomic dysrefl exia is a potentially dangerous clinical syndrome that develops in individuals with SCI. Autonomic dysrefl exia develops in individuals with a neurologic level of SCI at or above the level of sixth thoracic vertebra. Th e severity and neurological level of SCI have major impact on the autonomic nervous system function 19 . In individuals with intact central and peripheral nervous systems, a noxious stimulus results initially in a sympathetic response, leading to elevation in heart rate and blood pressure primarily through spinal refl exes. Th is response is modulated by the central nervous system and peripheral baroreceptors through the parasympathetic nervous system; it results in heart rate and blood pressure control both through direct responses by the vagus nerve and through inhibitory spinal cord signals. An appropriate balance of sympathetic and parasympathetic outfl ow is attained and modulated by both the central and peripheral nervous systems 20 . In tetraplegic individuals with complete lesions, disconnection of the spinal sympathetic neurons from cerebral control represents a unique possibility for analysis of the sympathetic infl uence on HRV 19 . Th e underlying pathophysiological changes that occur in the spinal cord and periphery causing autonomic dysrefl exia have not been fully elucidated in a human model.
During the fi rst week after SCI, disorder of autonomic functions can be life-threatening, especially due to development of bradycardia or even asystole. Cervical SCI has been associated with an increased risk of ECG = electrocardiography; HRV = heart rate variability; SCI = spinal cord injury; p = test of statistical signifi cance; values are expressed as mean ± standard deviation (SD); TP = total power; P = power; VLF = very low frequency; LF = low frequency; HF = high frequency; LF/HF = low to high frequency ratio.
mortality from several cardiovascular diseases, including both ischemic and non-ischemic heart disease 21 . Th erefore, rhythm disorders and conduct disorders as the most common cardiovascular complications are still a major cause of mortality after trauma to cervical spine and spinal cord.
Tetraplegic patients are deprived of supraspinal sympathoadrenal control, but have intact eff erent pathways. Interruption in the spinal cord of eff erent sympathetic pathways from central centers leads to pathologic changes in the activity of the peripheral sympathetic nervous system. In complete high-level SCI, functioning in the isolated spinal cord below the lesion becomes independent of supraspinal control and has been termed 'decentralization' of the sympathetic nervous system 5 . Recently developed methods may be particularly useful in evaluating function of autonomic nervous system and the eff ects of certain drugs on the cardiovascular function in individuals with SCI. Specifi cally, power spectral analysis of HRV has become commonly used as a noninvasive method to quantify autonomic control of the cardiovascular system 12 . Permanent changes in the sympathetic and parasympathetic autonomic nervous system cause changes in heart rate and fl uctuations in the average heart rate.
In our study, HRV was calculated from 24-hour Holter ECG, which is the optimal index of neural control of the heart 12 . In a previously published paper, we have reported on the predominance of n. parasympathetic and altered sympathovagal balance in acute SCI. In their study, Malmqvist et al. demonstrated a lower mean LF/HF ratio in the C1-T5 group as compared with the T6-T12 group, indicating that diminished sympathetic activity in these patients results in lower values of LF, which could refl ect a less aff ected sympathovagal balance in the latter group. Th eir results were similar to ours, suggesting that LF is partly mediated by sympathetic fi bers, which supports the assumption that LF/HF ratio can serve as a measure of the sympathovagal balance since HF is mediated entirely by vagal control 19 . In high-level SCI, the sympathetic nervous system is disproportionately involved when compared with the parasympathetic nervous system 5 . However, the fact that LF is not absent after complete injury to cervical spine suggests that the sympathetic control of the heart is modulated by rhythmic discharges by spinal sympathetic neurons, although without supraspinal control.
Previous studies on the eff ects of certain drugs on HRV did not provide defi nitive conclusions when HRV is directly related to the eff ect of certain medications. It is known that beta-receptor antagonists, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers aff ect HRV and are not administered without previous testing [22] [23] [24] [25] [26] . Th e antiarrhythmics propafenone and fl ecainide reduce HRV 27 . Infl ammation can cause further damage to the spinal cord and patients are treated with drugs to reduce swelling.
Th e National Acute Spinal Cord Injury Studies (NASCIS) II and III, and a Cochrane Database of Systematic Reviews article of all randomized clinical trials have verifi ed signifi cant improvement in motor function and sensation in patients with complete or incomplete SCI treated with high doses of methylprednisolone within 8 hours of injury 28, 29 . We tried to see if corticosteroids had infl uence on HRV. Analysis of the HRV parameters in the time domain showed that SDANN and SDNN as measures of total HRV were slightly but not signifi cantly decreased in the group with SCI having received corticosteroid therapy as compared with the SCI group without therapy. RMSSD was also decreased in the group on corticosteroid therapy, while NN50 and pNN50 as measures of parasympathetic activity were also slightly but not signifi cantly increased in the SCI group having received corticosteroid therapy.
Reduced HRV is associated with increased morbidity and mortality. It can be assumed that reduced HRV could also be a predictor of morbidity and mortality in subjects after trauma of the cervical spine 30 . Analysis of the HRV parameters in the frequency domain showed that low frequency was lower and high frequency higher in the SCI group on corticosteroid therapy as compared with the SCI group without corticosteroid therapy, but the diff erence did not reach statistical signifi cance. Th e low to high frequency ratio (LF/HF) did not diff er statistically signifi cantly (p=0.858) between the two SCI groups. Accordingly, analysis of the HRV parameters in the time and frequency domains showed no signifi cant diff erence between the groups of SCI patients having and not having received corticosteroid therapy.
Stein et al. analyzed HRV in patients with systemic lupus erythematosus with and without corticosteroid treatment. Time and frequency domain HRV indices were signifi cantly reduced in the systemic lupus erythematosus groups with and without corticosteroid therapy, as compared with controls. However, the indices were not signifi cantly diff erent between the two systemic lupus erythematosus groups 31 . In conclusion, SCI causes dysfunction of the autonomic cardiovascular regulation demonstrated by the spectral measures of HRV. Analysis of autonomic function is related to clinical measures of autonomic nervous system after acute SCI and provides a useful noninvasive clinical marker that can help assess the severity of damage to the autonomic pathways. Th ese measures may also prove useful in evaluating changes in the autonomic function over time or due to interventions aimed at improving autonomic function after SCI and particularly in assessing the eff ects of certain drugs on the autonomic nervous system.
Finally, a high dose of methylprednisolone can improve motor function and sensation in patients with complete or incomplete SCI 28, 29 , but cannot improve the sympathovagal balance. We did not fi nd any effects of corticosteroids on HRV parameters. However, additional research is needed in the fi eld.
